NCT04342676View on ClinicalTrials.gov

Lymph Node Ratio and Kras Mutation in R Colon Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

433

Participants

Timeline

Start Date

March 10, 2017

Primary Completion Date

August 25, 2019

Study Completion Date

August 26, 2019

Conditions
Colon Cancer Stage III
Interventions
DEVICE

k ras

K ras

DRUG

Panitumumab

vectibex in stage iv

Trial Locations (1)

35516

Mansoura University Oncology Center, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT04342676 - Lymph Node Ratio and Kras Mutation in R Colon Cancer | Biotech Hunter | Biotech Hunter